pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    APHD-012
    Obesity Aphaia Pharma AG
  • Phase 2
    APL-2302
    Breast Cancer Asieris Pharmaceuticals (USA) Inc
  • Phase 2
    APPA-02
    Resistant Pseudomonas aeruginosa Infections$ARMP Armata Pharmaceuticals, Inc.
  • Phase 2
← prev
page 5 of 53
next →
131
Pain89
Neurology1
APS-03118
Medullary Thyroid Cancer
Applied Pharmaceutical Science Inc
  • Phase 2
    APSA-02
    Bacteremia$ARMP Armata Pharmaceuticals, Inc.
  • Phase 2
    APTA-16
    Myelodysplastic Syndrome (Preleukemia) AptaBio Therapeutics Inc
  • Phase 2
    ARCT-032
    Cystic Fibrosis$ARCT Arcturus Therapeutics Holdings Inc.
  • Phase 2
    ARCT-165
    Coronavirus Disease 2019 (COVID-19) Seqirus Ltd
  • Phase 2
    ARCT-810
    Ornithine-Transcarbamylase Deficiency$ARCT Arcturus Therapeutics Holdings Inc.
  • Phase 2
    ARD-103
    Refractory Acute Myeloid Leukemia ARCE Therapeutics Inc
  • Phase 2
    ART-6043
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Artios Pharma Ltd
  • Phase 2
    ARTHEx-01
    Myotonic Dystrophy ARTHEx Biotech SL
  • Phase 2
    ARTS-021
    Endometrial Cancer Avenzo Therapeutics Inc
  • Phase 2
    ARTS-023
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Avenzo Therapeutics Inc
  • Phase 2
    ARV-806
    Colorectal Cancer$ARVN ARVINAS, INC.
  • Phase 2
    ASC-30
    Obesity Ascletis Pharma Inc
  • Phase 2
    ASC-618
    Hemophilia A (Factor VIII Deficiency) ASC Therapeutics Inc
  • Phase 2
    ASP-2957
    X-Linked Myotubular Myopathy (XLMTM or MTM) Astellas Pharma Inc
  • Phase 2
    ASP-7316
    Juvenile Macular Degeneration (Stargardt Disease) Astellas Pharma Inc
  • Phase 2
    ATA-200
    Limb-Girdle Muscular Dystrophy Atamyo Therapeutics SAS
  • Phase 2
    ATH-434
    Multiple System Atrophy (Multi-System Degeneration)$ATHE ALTERITY THERAPEUTICS LTD
  • Phase 2
    ATR-04
    Skin Rash$AZTR Azitra, Inc.
  • Phase 2
    ATRN-119
    Ovarian Cancer$APRE Aprea Therapeutics, Inc.
  • Phase 2
    ATSN-101
    Leber Congenital Amaurosis (LCA) Atsena Therapeutics Inc
  • Phase 2
    ATX-295
    Ovarian Cancer Accent Therapeutics Inc
  • Phase 2
    AUTO-3
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$AUTL Autolus Therapeutics plc
  • Phase 2
    AV-0328
    Streptococcal Pneumonia Alopexx Inc
  • Phase 2
    AV-1
    Dengue Fever AbViro LLC
  • Phase 2
    AV-101
    Major Depressive Disorder$VTGN Vistagen Therapeutics, Inc.
  • Phase 2
    AVB-101
    Frontotemporal Dementia (Pick Disease) AviadoBio Ltd